Corporate Spotlight
An Emerging Global Leader in the New Generation of Anti-Infective Therapies
Recce Pharmaceuticals Ltd (ASX:RCE) is an Australian based globally-focussed, biotechnology company engaged in the development and commercialisation of a new class of synthetic anti-infectives.
View the full Corporate Spotlight
RCE TO DUAL LIST on Frankfurt Stock Exchange (FSE)
Latest Threads
ASX News
Hot News
TheMarketHeraldSee All Discussions
Corporate Spotlight
- RCE TO DUAL LIST ON FSE
- RCE ADVANCES CLINICAL TRIALS BURNS STUDY
- RCE POSTS STRONG RESULTS AGAINST COVID
- RCE BANKS $900K R&D REBATE
- RCE REVEALS HIGHLIGHTS FROM DEC QTR
- RCE POSTS POSITIVE FINDINGS COVID STUDY
- RCE AWARDED ANOTHER BIG R&D REBATE
- RCE GRANTED OVERSEAS R&D KICKBACK
- RCE VIRUS TREATMENT GRANTED PATENT JAPAN
- RCE SURGES POSITIVE ANTI-COVID RESULTS
- INVESTOR PRESENATION
- RCE APPROVAL TO START BURNS STUDY
- ABOUT US
- VIDEOS
Timeline
|
|
||||
|
|
|
||||
|
|
|
||||
|
|
|
||||
|
|
|
||||
|
|
|
||||
| View More | |||||
 (20min delay)
|
|||||
|
Last
$1.02 |
Change
-0.020(1.93%) |
Mkt cap ! $176.3M | |||
| Open | High | Low | Value | Volume |
| $1.04 | $1.04 | 99.5¢ | $138.1K | 137.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 78400 | 99.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.02 | 2673 | 1 |
View Market Depth
| Last trade - 16.10pm 04/03/2021 (20 minute delay) ? |
 (live)
|
|||||
|
Last
$1.00 |
Change
-0.020 ( 1.52 %) |
||||
| Open | High | Low | Volume | ||
| $1.00 | $1.01 | 99.5¢ | 55258 | ||
| Last updated 15.58pm 04/03/2021 (live) ? | |||||
| RCE (ASX) Chart |